We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Drug Development Meetings

Drug Development Meetings

June 15, 2006

Join FDAnews Thursday, June 22, for "Corrective and Preventive Action Systems: Leverage Data From the FDA's Own CAPA Training Program." In this 90-minute audioconference with Q&A session, former FDA investigator Martin Browning will focus on data taken directly from the FDA's own CAPA training program. He will discuss regulatory expectations and the real benefits of an effective CAPA system. On June 27, join FDAnews for "Preparing for an FDA Preapproval Inspection." In this 90-minute audioconference, 34-year FDA veteran Bill Ment will show you how to prepare for and manage preapproval inspections to avoid misunderstandings, prevent delays in the approval process and eliminate unnecessary costs.

June 15-16: Monitoring Clinical Drug Studies: Intermediate Chicago, Ill. (610) 548-2200 Barnett Educational Services customer.service@parexel.com www.barnettinternational.com/index-flash.html

June 19-20: Drug Development and FDA Regulations Boston, Mass. (610) 548-2200

Barnett Educational Services customer.service@parexel.com www.barnettinternational.com/index-flash.html

June 20-21: Complying with the EU Clinical Trial Directive Boston (212) 661-3250 PTi international dweinberg@pti-international.com www.pti-international.com

June 22-23: ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development Irvine, Calif. (610) 688-1708 The Center for Professional Innovation and Education

info@cfpie.com www.cfpie.com/showitem.aspx?productid=090&source=fdanewsconferencecalendarfree

June 26-27: Clinical Trials in Cancer London, UK +44 (0)20 7827 6088 SMi Group Ltd dmorgan@smi-online.co.uk www.smi-online.co.uk/ctcancer.asp

June 29-30: Clinical Statistics for Non Statisticians Amsterdam, the Netherlands

(215) 442-6100 Drug Information Association dia@diahome.org www.diahome.org

June 29-30: Project Management in Drug Development: Phase I and Phase II Clinical Development

Philadelphia, Pa. (212) 661-3500 PTi international dweinberg@pti-international.com

www.pti-international.com

July 10-11: Trial Design Innovation Washington, D.C . (212) 400-6240 ExL Pharma fcasanova@exlpharma.com www.exlpharma.com/index.php

June 20-21: Complying with the EU Clinical Trial Directive Boston (212) 661-3250 PTi international dweinberg@pti-international.com www.pti-international.com

June 22-23: ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development Irvine, Calif. (610) 688-1708 The Center for Professional Innovation and Education

info@cfpie.com www.cfpie.com/showitem.aspx?productid=090&source=fdanewsconferencecalendarfree

June 26-27: Clinical Trials in Cancer London, UK +44 (0)20 7827 6088 SMi Group Ltd dmorgan@smi-online.co.uk www.smi-online.co.uk/ctcancer.asp

June 29-30: Clinical Statistics for Non Statisticians Amsterdam, the Netherlands

(215) 442-6100 Drug Information Association dia@diahome.org www.diahome.org

KEYWORDS Drug Pipeline Alert

Upcoming Events

  • 19Jan

    Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management

  • 21Jan

    Virtual MDSAP Audits in the Era of COVID-19: What to Know and Do to Pass Virtual Audits

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 27Jan

    FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations

  • 09Feb

    Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Regeneron logo

    U.S. Government Orders More Supplies of Regeneron’s COVID-19 Antibody Cocktail

  • Siemens Healthineers logo

    Siemens Healthineers COVID Test Gets Additional Sampling Method Clearance

  • COVID-19  Clinical Trial

    Synairgen Initiates Dosing in Late-Stage Trial of Inhaled COVID-19 Therapy

  • Verona Pharma logo

    Verona Pharma Ends Enrollment in Inhaler-Administered COVID-19 Drug Pilot

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing